Homepage601607 • SHA
add
Shanghai Pharmaceuticals Holding Ord Shs A
Vorige slotkoers
¥ 17,88
Dag-range
¥ 17,86 - ¥ 17,99
Jaar-range
¥ 17,28 - ¥ 22,29
Beurswaarde
59,92Â mld. CNY
Gem. volume
14,64Â mln.
Koers/winst
11,81
Dividendrendement
-
Primaire beurs
SHA
Marktnieuws
Financiële informatie
Resultatenrekening
Opbrengst
Netto inkomsten
| (CNY) | sep 2025info | Wijziging j-o-j |
|---|---|---|
Opbrengst | 73,48Â mld. | 4,65% |
Bedrijfskosten | 5,58Â mld. | 14,38% |
Netto inkomsten | 688,20Â mln. | -38,13% |
Netto winstmarge | 0,94 | -40,51% |
Winst per aandeel | — | — |
EBITDA | 2,26Â mld. | -13,12% |
Effectief belastingtarief | 32,89% | — |
Balans
Totale activa
Totale passiva
| (CNY) | sep 2025info | Wijziging j-o-j |
|---|---|---|
Contanten en kortetermijnbeleggingen | 44,55Â mld. | 5,10% |
Totale activa | 236,75Â mld. | 5,81% |
Totale passiva | 147,12Â mld. | 4,65% |
Totaal aandelenvermogen | 89,62 mld. | — |
Uitstaande aandelen | 3,71 mld. | — |
Koers-boekwaardeverhouding | 0,87 | — |
Rendement op activa | 1,98% | — |
Rendement op kapitaal | 3,14% | — |
Kasstroom
Nettomutatie in liquide middelen
| (CNY) | sep 2025info | Wijziging j-o-j |
|---|---|---|
Netto inkomsten | 688,20Â mln. | -38,13% |
Operationele kasstroom | 1,36Â mld. | -40,00% |
Kasstroom uit beleggingen | 449,96Â mln. | 126,86% |
Kasstroom uit financiering | -4,31Â mld. | -18,77% |
Nettomutatie in liquide middelen | -2,49Â mld. | 18,18% |
Vrije kasstroom | -3,15Â mld. | -7,21% |
Over
Shanghai Pharmaceuticals is a private-sector Chinese pharmaceutical company. The organization develops and distributes pharmaceutical products and operates in domestic and international markets.
Shanghai Pharma is the largest pharmaceutical and the first A+H listed company in China to be dual-listed by Shanghai and Hong Kong Stock Exchanges. As of year 2020, the company made its presence to the Global Fortune 500 list with the ranking of 473, overall and 124 among 21 other Chinese companies on the list.
Shanghai Pharmaceuticals was founded in 1994 and is headquartered in Shanghai. As an investment holding company, it is actively engaged in research, manufacturing and distribution of pharmaceutical and healthcare products in China, that develops and distributes traditional Chinese and chemical drugs, chemical, biochemical and healthcare goods that are applied in various therapeutic fields, including immunoregulation and anti-cancer, immune system and digestion, cardiovascular and anti-infection, nervous system and mental disorder. Wikipedia
Opgericht
18 jan 1994
Website
Werknemers
50.120